Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
نویسندگان
چکیده
Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the selection agents in clinical practice.
منابع مشابه
Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.
In eight mechanically ventilated patients in cardiogenic shock, we assessed the hemodynamic effects of an infusion of dopamine and dobutamine and evaluated its role in preventing the deleterious effects of administering each amine alone. Each patient received three infusions in a randomly assigned order: dopamine, 15 micrograms/kg/min; dobutamine, 15 micrograms/kg/min; and a combination of dopa...
متن کاملmodern surgical techniques in treatment of patients with cleft lip & cleft palate
چکیده ندارد.
15 صفحه اولThe effects of dopamine, dobutamine and amrinone on mitochondrial function in cardiogenic shock.
The impairment of mitochondrial in non-infarcted myocardium under cardiogenic shock complicated by acute myocardial infarction was studied. We induced acute myocardial infarction in dogs by ligating the circumflex branch of the left coronary artery (LCX). On basis of left ventricular systolic pressure (LVPs) after 60 minutes, we divided the dogs into two groups: a group in which LVPs fell to be...
متن کاملCardiogenic Shock with Imipramine
A 35 years old physically healthy individual, being treated far depression with imipramine and electroplexy, developed cardiogenic shock which was managed successfully with inotropic support. The case is presented to highlight a rare and potentially fatal side effect of tricyclic anti-depressants.
متن کاملTreatment Options in Cardiogenic Shock with Intra-aortic Balloon Counterpulsation
Cardiogenic shock (CS), a state of inadequate tissue perfusion due to cardiac dysfunction, remains the leading cause of death following acute myocardial infarction (AMI). While the prognosis of CS post-AMI has improved in recent decades due to advances in treatment modalities, the mortality rates remain unacceptably high (~40–50% according to recent registries and clinical trials). Current trea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The New England Journal of Medicine
سال: 2021
ISSN: ['0028-4793', '1533-4406']
DOI: https://doi.org/10.1056/nejmoa2026845